Drug Profile
Usistapide
Alternative Names: JNJ-16269110; JNJ1629110; R-256918Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Johnson & Johnson
- Class Acetic acids; Amides; Antihyperglycaemics; Obesity therapies; Piperidines; Small molecules
- Mechanism of Action Microsomal triglyceride transfer protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus